Published

Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.

An abstract is available from the original source but is not redistributed by this tracker. Read the source record.

Open source BibTeX RIS

Bibliographic context

Journal: Journal of psychopharmacology (Oxford, England)
Date: 2016-12-01
Source: PubMed
DOI: 10.1177/0269881116662634
PubMed: 27578767

Authors

Carbonaro TM Bradstreet MP Barrett FS MacLean KA Jesse R Johnson MW Griffiths RR

Watch author

Derived topics and classifications

psilocybin Wellbeing Observational Study Safety Observational Study

Citation graph

0 referenced DOIs found in stored source metadata. 5 indexed papers cite this DOI.

Open citation network

Indexed papers citing this DOI

Psilocybin-Assisted Therapy in Psychiatry: A Narrative Clinical Review of Mechanisms, Therapeutic Applications, and Emerging Evidence (2025-2026)2026-08-12 Acceptability and safety of two sequential doses of psilocybin in bipolar II depression: protocol for an open-label single-arm feasibility study2026-07-01 Long-Term Efficacy of Psilocybin with Adjunct Psychotherapy in Treatment-Resistant Major Depression: 6- and 12-Month Naturalistic Follow-Up of a Phase 2b Trial2026-05-27 Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts2026-05-01 Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.2016-12-01

Related papers

Microdosing Psychedelics to Improve MoodClinicalTrials.gov · 2025-12-30 A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?ClinicalTrials.gov · 2025-10-29 Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy SubjectsClinicalTrials.gov · 2026-06-25 Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy SubjectsClinicalTrials.gov · 2025-03-05 Psilocybin Administration With 5-HT1a BlockadeClinicalTrials.gov · 2026-08-14 Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord InjuryClinicalTrials.gov · 2026-08-10 Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of PsilocybinClinicalTrials.gov · 2026-07-29 Psilocybin and Affective Function in Chronic Lower Back Pain DepressionClinicalTrials.gov · 2026-07-24